[1]
|
Jung RM, Rybak M, Milner P, et al. Local anesthetics and advances in their administration-an overview[J]. J Pre-Clin Clin Res, 2017, 11: 94-101. doi: 10.26444/jpccr/75153 |
[2]
|
El-Boghdadly K, Pawa A, Chin KJ. Local anesthetic systemic toxicity: current perspectives[J]. Local Reg Anesth, 2018, 11: 35-44. doi: 10.2147/LRA.S154512 |
[3]
|
Jasinski T, Migon D, Sporysz K, et al. The Density of Different Local Anesthetic Solutions, Opioid Adjuvants and Their Clinically Used Combinations: An Experimental Study[J]. Pharmaceuticals (Basel), 2021, 14: 801. doi: 10.3390/ph14080801 |
[4]
|
Zhao C, Liu A, Santamaria CM, et al. Polymer-tetrodotoxin conjugates to induce prolonged duration local anesthesia with minimal toxicity[J]. Nat Commun, 2019, 10: 2566. doi: 10.1038/s41467-019-10296-9 |
[5]
|
Hagen NA, Cantin L, Constant J, et al. Tetrodotoxin for Moderate to Severe Cancer-Related Pain: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Trial[J]. Pain Res Manag, 2017, 2017: 7212713. |
[6]
|
Visciano P, Schirone M, Berti M, et al. Marine Biotoxins: Occurrence, Toxicity, Regulatory Limits and Reference Methods[J]. Front Microbiol, 2016, 7: 1051. doi: 10.3389/fmicb.2016.01051 |
[7]
|
Belgi A, Burnley JV, MacRaild CA, et al. Alkyne-Bridged α-Conotoxin Vc1.1 Potently Reverses Mechanical Allodynia in Neuropathic Pain Models[J]. J Med Chem, 2021, 64: 3222-3233. doi: 10.1021/acs.jmedchem.0c02151 |
[8]
|
Rwei AY, Paris JL, Wang B, et al. Ultrasound-triggered local anaesthesia[J]. Nat Biomed Eng, 2017, 1: 644-653. doi: 10.1038/s41551-017-0117-6 |
[9]
|
Zhan C, Wang W, Santamaria C, et al. Ultrasensitive Phototriggered Local Anesthesia[J]. Nano Lett, 2017, 17: 660-665. doi: 10.1021/acs.nanolett.6b03588 |
[10]
|
Richard BM, Rickert DE, Doolittle D, et al. DepoFoamⓇ Bupivacaine (EXPARELTM) is Compatible Following Lidocaine: Pharmacokinetic Study in Mini-pigs[J]. FASEB, 2011, 25: 392. |
[11]
|
曾慧琳, 施震, 符旭东. 布比卡因脂质体注射用悬浮液Exparel临床应用研究进展[J]. 中国新药杂志, 2014, 23: 1654-1657. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXYZ201414019.htm
Zeng HL, Shi Z, Fu XD. Progress in clinical application of the bupivacaine liposome injectable suspension Exparel[J]. Zhongguo Xinyao Zazhi, 2014, 23: 1654-1657. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXYZ201414019.htm |
[12]
|
Poon W, Kingston BR, Ouyang B, et al. A framework for designing delivery systems[J]. Nat Nanotechnol, 2020, 15: 819-829. doi: 10.1038/s41565-020-0759-5 |
[13]
|
Tu Z, Zhong Y, Hu H, et al. Design of therapeutic biomaterials to control inflammation[J]. Nat Rev Mater, 2022, 28: 1-18. |
[14]
|
Surve DH, Jindal AB. Recent advances in long-acting nanoformulations for delivery of antiretroviral drugs[J]. J Control Release, 2020, 324: 379-404. doi: 10.1016/j.jconrel.2020.05.022 |
[15]
|
Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications[J]. Adv Drug Deliv Rev, 2013, 65: 36-48. doi: 10.1016/j.addr.2012.09.037 |
[16]
|
Grimaldi N, Andrade F, Segovia N, et al. Lipid-based nanovesicles for nanomedicine[J]. Chem Soc Rev, 2016, 45: 6520-6545. doi: 10.1039/C6CS00409A |
[17]
|
Chang HI, Yeh MK. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy[J]. Int J Nanomedicine, 2012, 7: 49-60. |
[18]
|
McAlvin JB, Padera RF, Shankarappa SA, et al. Multivesicular liposomal bupivacaine at the sciatic nerve[J]. Biomaterials, 2014, 35: 4557-4564. doi: 10.1016/j.biomaterials.2014.02.015 |
[19]
|
Epstein-Barash H, Shichor I, Kwon AH, et al. Prolonged duration local anesthesia with minimal toxicity[J]. PNAS, 2009, 106: 7125-7130. doi: 10.1073/pnas.0900598106 |
[20]
|
Liechty WB, Kryscio DR, Slaughter BV, et al. Polymers for drug delivery systems[J]. Annu Rev Chem Biomol Eng, 2010, 1: 149-173. doi: 10.1146/annurev-chembioeng-073009-100847 |
[21]
|
D'souza AA, Shegokar R. Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications[J]. Expert Opin Drug Deliv, 2016, 13: 1257-1275. doi: 10.1080/17425247.2016.1182485 |
[22]
|
Knop K, Hoogenboom R, Fischer D, et al. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives[J]. Angew Chem Int Ed Engl, 2010, 49: 6288-6308. doi: 10.1002/anie.200902672 |
[23]
|
Lü JM, Wang X, Marin-Muller C, et al. Current advances in research and clinical applications of PLGA-based nanotechnology[J]. Expert Rev Mol Diagn, 2009, 9: 325-341. doi: 10.1586/erm.09.15 |
[24]
|
Danhier F, Ansorena E, Silva JM, et al. PLGA-based nanoparticles: an overview of biomedical applications[J]. J Control Release, 2012, 161: 505-522. doi: 10.1016/j.jconrel.2012.01.043 |
[25]
|
Zhang W, Xu W, Ning C, et al. Long-acting hydrogel/microsphere composite sequentially releases dexmedetomidine and bupivacaine for prolonged synergistic analgesia[J]. Biomaterials, 2018, 181: 378-391. doi: 10.1016/j.biomaterials.2018.07.051 |
[26]
|
He Y, Qin L, Fang Y, et al. Electrospun PLGA nanomembrane: A novel formulation of extended-release bupivacaine delivery reducing postoperative pain[J]. Mat Des, 2020, 193: 108768. |
[27]
|
Khandare J, Minko T. Polymer-drug conjugates: Progress in polymeric prodrugs[J]. Prog Polym Sci, 2006, 31: 359-397. doi: 10.1016/j.progpolymsci.2005.09.004 |
[28]
|
Gu Z, Dong Y, Xu S, et al. Molecularly Imprinted Polymer-Based Smart Prodrug Delivery System for Specific Targeting, Prolonged Retention, and Tumor Microenvironment-Trig-gered Release[J]. Angew Chem Int Ed Engl, 2021, 60: 2663-2667. doi: 10.1002/anie.202012956 |
[29]
|
Dragojevic S, Ryu JS, Raucher D. Polymer-Based Pro-drugs: Improving Tumor Targeting and the Solubility of Small Molecule Drugs in Cancer Therapy[J]. Molecules, 2015, 20: 21750-21769. doi: 10.3390/molecules201219804 |
[30]
|
Tang J, Meka AK, Theivendran S, et al. Openwork@Dendritic Mesoporous Silica Nanoparticles for Lactate Depletion and Tumor Microenvironment Regulation[J]. Angew Chem Int Ed Engl, 2020, 59: 22054-22062. doi: 10.1002/anie.202001469 |
[31]
|
Xu C, Lei C, Wang Y, et al. Dendritic Mesoporous Nanoparticles: Structure, Synthesis and Properties[J]. Angew Chem Int Ed Engl, 2022, 61: e202112752. |
[32]
|
Ghosh D, Lee Y, Thomas S, et al. M13-templated magnetic nanoparticles for targeted in vivo imaging of prostate cancer[J]. Nat Nanotechnol, 2012, 7: 677-682. doi: 10.1038/nnano.2012.146 |
[33]
|
Wang C, Chen J, Talavage T, et al. Gold nanorod/Fe3O4 nanoparticle "nano-pearl-necklaces" for simultaneous targeting, dual-mode imaging, and photothermal ablation of cancer cells[J]. Angew Chem Int Ed Engl, 2009, 48: 2759-2763. doi: 10.1002/anie.200805282 |
[34]
|
Wu M, Zhang X, Zhang W, et al. Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis[J]. Nat Commun, 2022, 13: 1371. doi: 10.1038/s41467-022-29018-9 |
[35]
|
Tsvetkov P, Coy S, Petrova B, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins[J]. Science, 2022, 375: 1254-1261. doi: 10.1126/science.abf0529 |
[36]
|
Ji T, Li Y, Deng X, et al. Delivery of local anaesthetics by a self-assembled supramolecular system mimicking their interactions with a sodium channel[J]. Nat Biomed Eng, 2021, 5: 1099-1109. doi: 10.1038/s41551-021-00793-y |
[37]
|
Liu X, Situ A, Kang Y, et al. Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic Cancer[J]. ACS Nano, 2016, 10: 2702-2715. doi: 10.1021/acsnano.5b07781 |
[38]
|
Heng PWS. Controlled release drug delivery systems[J]. Pharm Dev Technol, 2018, 23: 833. doi: 10.1080/10837450.2018.1534376 |
[39]
|
Zhan C, Santamaria CM, Wang W, et al. Long-acting liposomal corneal anesthetics[J]. Biomaterials, 2018, 181: 372-377. doi: 10.1016/j.biomaterials.2018.07.054 |
[40]
|
Weldon C, Ji T, Nguyen MT, et al. Nanoscale Bupivacaine Formulations To Enhance the Duration and Safety of Intravenous Regional Anesthesia[J]. ACS Nano, 2019, 13: 18-25. doi: 10.1021/acsnano.8b05408 |
[41]
|
Liu Q, Santamaria CM, Wei T, et al. Hollow Silica Nanoparticles Penetrate the Peripheral Nerve and Enhance the Nerve Blockade from Tetrodotoxin[J]. Nano Lett, 2018, 18: 32-37. doi: 10.1021/acs.nanolett.7b02461 |
[42]
|
Sirsi SR, Borden MA. State-of-the-art materials for ultrasound-triggered drug delivery[J]. Adv Drug Deliv Rev, 2014, 72: 3-14. doi: 10.1016/j.addr.2013.12.010 |
[43]
|
Rwei AY, Wang W, Kohane DS. Photoresponsive nanoparticles for drug delivery[J]. Nano Today, 2015, 10: 451-467. doi: 10.1016/j.nantod.2015.06.004 |
[44]
|
Lee H, Song C, Baik S, et al. Device-assisted transdermal drug delivery[J]. Adv Drug Deliv Rev, 2018, 127: 35-45. doi: 10.1016/j.addr.2017.08.009 |